AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1987875 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-cushion lithotriptor at high energy levels (group C)
Number of subjects: 711
Study 1987875 — intervention group
Group type: EXPERIMENTAL
Intervention: Bile acid therapy compliance
Number of subjects: 711
Study 1987875 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 711
Study 6857584 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg four times daily)
Number of subjects: 2
Study 6857584 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 2
Study 31646460 — intervention group
Group type: EXPERIMENTAL
Intervention: KIM-1 staining
Number of subjects: 184
Study 31646460 — intervention group
Group type: EXPERIMENTAL
Intervention: KIM-1/sCr ratio
Number of subjects: 184
Study 29447379 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise 24 hours preoperatively (EX group)
Number of subjects: 20
Study 29447379 — intervention group
Group type: COMPARATOR
Intervention: Standard presurgical procedures (Control group)
Number of subjects: 20
Study 25601896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular single dose of 300,000 IU vitamin D3
Number of subjects: 60
Study 25601896 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 60
Study 25024660 — intervention group
Group type: EXPERIMENTAL
Intervention: AASM recommended EEG montage (F4‐M1, C4‐M1, O2‐M1)
Number of subjects: 50
Study 25024660 — intervention group
Group type: COMPARATOR
Intervention: AASM acceptable EEG montage (Fz‐Cz, C4‐M1, Oz‐Cz)
Number of subjects: 50
Study 23127390 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based sizing recommendations for TAVR
Number of subjects: 120
Study 23127390 — intervention group
Group type: COMPARATOR
Intervention: TEE sizing
Number of subjects: 120
Study 20544489 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (12 weeks, 5 days a week)
Number of subjects: 18
Study 17953631 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant pool (AP) supplementation for 2 months before and 6 months during NB‐UVB treatment
Number of subjects: 35
Study 17953631 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant pool (AP) supplementation
Number of subjects: 35
Study 17953631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 16367987 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 210
Study 16367987 — intervention group
Group type: COMPARATOR
Intervention: Lofexidine
Number of subjects: 210
Study 16367987 — intervention group
Group type: EXPERIMENTAL
Intervention: Not completing detoxification (both groups)
Number of subjects: 210
Study 12037659 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml tomato juice with 300 mg HCA
Number of subjects: 24
Study 12037659 — intervention group
Group type: COMPARATOR
Intervention: 100 ml tomato juice (placebo)
Number of subjects: 24
Study 12555375 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (nitrendipine associated with enalapril or hydrochlorothiazide)
Number of subjects: 2418
Study 12555375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2418
Study 8904587 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% O2
Number of subjects: 8
Study 8904587 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% O2 (isocapnic)
Number of subjects: 8
Study 8904587 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% O2 (poikilocapnic)
Number of subjects: 8
Study 1800166 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2-(2-Hydroxy-4-methylphenyl) Aminothiazole Hydrochloride 0.1% (CBS 113A)
Number of subjects: 43
Study 1800166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 6391903 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil (30 ml)
Number of subjects: 29
Study 6391903 — intervention group
Group type: EXPERIMENTAL
Intervention: Linseed oil (30 ml)
Number of subjects: 29
Study 6391903 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 29
Study 31542293 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 0
Study 31542293 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 0
Study 29526850 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation therapy
Number of subjects: 0
Study 29526850 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychotherapy
Number of subjects: 0
Study 29526850 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Transcranial Direct Current Stimulation + Positive psychotherapy)
Number of subjects: 0
Study 26953280 — intervention group
Group type: EXPERIMENTAL
Intervention: U‐300 insulin glargine
Number of subjects: 6
Study 26953280 — intervention group
Group type: COMPARATOR
Intervention: U‐100 insulin glargine
Number of subjects: 6
Study 25070099 — intervention group
Group type: COMPARATOR
Intervention: 7-day standard triple therapy (pantoprazole, clarithromycin, amoxicillin for 7 days)
Number of subjects: 307
Study 25070099 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day sequential therapy (pantoprazole and amoxicillin for 5 days, followed by pantoprazole, clarithromycin, and metronidazole for a further 5 days)
Number of subjects: 307
Study 25070099 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day concomitant therapy (pantoprazole, clarithromycin, amoxicillin, and metronidazole for 7 days)
Number of subjects: 307
Study 23231777 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot and apple juice (BJ)
Number of subjects: 30
Study 23231777 — intervention group
Group type: COMPARATOR
Intervention: Placebo juice (PL)
Number of subjects: 30
Study 19898821 — intervention group
Group type: EXPERIMENTAL
Intervention: PFC Sigma fixed‐bearing total knee replacement
Number of subjects: 120
Study 19898821 — intervention group
Group type: COMPARATOR
Intervention: PFC Sigma rotating‐platform total knee replacement
Number of subjects: 120
Study 18382824 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg exercise group (n = 32)
Number of subjects: 63
Study 18382824 — intervention group
Group type: COMPARATOR
Intervention: Arm exercise group (n = 31)
Number of subjects: 63
Study 16029670 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% hydroquinone/0.3% retinol cream
Number of subjects: 0
Study 16029670 — intervention group
Group type: COMPARATOR
Intervention: 0.05% tretinoin emollient cream
Number of subjects: 0
Study 12482153 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic living-donor nephrectomy
Number of subjects: 100
Study 12482153 — intervention group
Group type: COMPARATOR
Intervention: Open donor nephrectomy
Number of subjects: 100
Study 10439767 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion (0.5 microgram.kg‐1.min‐1 i.v.)
Number of subjects: 100
Study 10439767 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 100
Study 7874593 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler echocardiography in patients with heart diseases
Number of subjects: 85
Study 7874593 — intervention group
Group type: COMPARATOR
Intervention: Doppler echocardiography in healthy volunteers
Number of subjects: 85
Study 7874593 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler echocardiography in patients
Number of subjects: 85
Study 2121150 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (30 g in red port and wine) consumed during a standard dinner
Number of subjects: 16
Study 698154 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper 7
Number of subjects: 281
Study 698154 — intervention group
Group type: EXPERIMENTAL
Intervention: Lippes loop D
Number of subjects: 281
Study 698154 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalkon shield
Number of subjects: 281
Study 698154 — intervention group
Group type: COMPARATOR
Intervention: All three IUCDs
Number of subjects: 281
Study 31408088 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive viewing of pictures
Number of subjects: 47
Study 31408088 — intervention group
Group type: COMPARATOR
Intervention: Fixation cross
Number of subjects: 47
Study 31541851 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component cognitive behavioral self-help intervention (MCT)
Number of subjects: 104
Study 31541851 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction intervention for insomnia (SRT)
Number of subjects: 104
Study 31541851 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 104
Study 28058769 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once weekly
Number of subjects: 2734
Study 28058769 — intervention group
Group type: COMPARATOR
Intervention: Exenatide twice daily
Number of subjects: 2734
Study 28058769 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 2734
Study 28058769 — intervention group
Group type: COMPARATOR
Intervention: DURATION-6 (Liraglutide)
Number of subjects: 2734
Study 26545669 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganoderma lucidum (6 g per day for 6 weeks)
Number of subjects: 64
Study 26545669 — intervention group
Group type: COMPARATOR
Intervention: Ceratonia siliqua (6 g per day for 6 weeks)
Number of subjects: 64
Study 24233110 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC) implemented after training and guideline establishment
Number of subjects: 98
Study 24233110 — intervention group
Group type: COMPARATOR
Intervention: Control group (before implementation of KMC)
Number of subjects: 98
Study 21525426 — intervention group
Group type: EXPERIMENTAL
Intervention: Group patient visits (4 sessions over 12 months)
Number of subjects: 30
Study 21525426 — intervention group
Group type: COMPARATOR
Intervention: Usual care (one‐on‐one)
Number of subjects: 30
Study 21525426 — intervention group
Group type: EXPERIMENTAL
Intervention: Group patient visits
Number of subjects: 30
Study 21525426 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study 19433812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive support program (implemented by nutrition and activity specialists)
Number of subjects: 200
Study 19433812 — intervention group
Group type: EXPERIMENTAL
Intervention: Inexpensive nurse-led program (involving weigh-ins and encouragement)
Number of subjects: 200
Study 19433812 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated-fat diet
Number of subjects: 200
Study 19433812 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet
Number of subjects: 200
Study 16923561 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab-CHOP-ESHAP
Number of subjects: 84
Study 16923561 — intervention group
Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 84
Study 16923561 — intervention group
Group type: COMPARATOR
Intervention: CHOP-ESHAP-HDT
Number of subjects: 84
Study 15457382 — intervention group
Group type: EXPERIMENTAL
Intervention: HT Immersion Medical Colonoscopy Simulator (no feedback)
Number of subjects: 26
Study 11769816 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 15
Study 11769816 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.2 mg
Number of subjects: 15
Study 11769816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9108861 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricomponent acellular pertussis-diphtheria-tetanus vaccine (fourth dose)
Number of subjects: 5361
Study 7848225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound assessment of fetal size (including femur length and abdominal circumference)
Number of subjects: 105
Study 7848225 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment of fetal size or weight
Number of subjects: 105
Study 7848225 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal femur length
Number of subjects: 105
Study 7848225 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal circumference
Number of subjects: 105
Study 7848225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound estimated fetal weight (using 3 different formulas: Shepard, Campbell and CUHK)
Number of subjects: 105
Study 3076140 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil 12.5 mg bid with Hydrochlorothiazide 12.5 mg bid
Number of subjects: 0
Study 3076140 — intervention group
Group type: COMPARATOR
Intervention: Pinacidil 12.5 mg bid
Number of subjects: 0
Study 3076140 — intervention group
Group type: COMPARATOR
Intervention: Pinacidil 25 mg bid
Number of subjects: 0
Study 3076140 — intervention group
Group type: COMPARATOR
Intervention: Pinacidil 37.5 mg bid
Number of subjects: 0
Study 3076140 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil with Hydrochlorothiazide
Number of subjects: 0
Study 3076140 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil (low doses 12.5-25 mg bid)
Number of subjects: 0
Study 31483187 — intervention group
Group type: EXPERIMENTAL
Intervention: App-connected ovulation test system (n=382)
Number of subjects: 844
Study 31483187 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=403)
Number of subjects: 844
Study 31229307 — intervention group
Group type: EXPERIMENTAL
Intervention: (F-18)Fluorodeoxyglucose positron emission tomography (FDG-PET) studies
Number of subjects: 0
Study 31229307 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (antipsychotic)
Number of subjects: 0
Study 31229307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27997282 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based physical activity and nutrition program for 6 months
Number of subjects: 417
Study 27997282 — intervention group
Group type: COMPARATOR
Intervention: Standard diet and physical activity advice on only one occasion (Control)
Number of subjects: 417
Study 28253848 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min computer-based Crew Resource Management (CRM) training
Number of subjects: 57
Study 28253848 — intervention group
Group type: COMPARATOR
Intervention: Control training on ethics
Number of subjects: 57
Study 23669822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral treprostinil (3.1 ± 1.9 mg bid)
Number of subjects: 310
Study 23669822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 21036692 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 26450
Study 21036692 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin
Number of subjects: 26450
Study 21036692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26450
Study 19439878 — intervention group
Group type: EXPERIMENTAL
Intervention: IL bleomycin (0.1% solution with concurrent anesthesia)
Number of subjects: 73
Study 19439878 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy (double freeze-thaw cycle)
Number of subjects: 73
Study 18042591 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) for induction therapy with corticosteroids for 24 weeks
Number of subjects: 358
Study 18042591 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) for maintenance therapy with corticosteroids
Number of subjects: 358
Study 18042591 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide for induction therapy with corticosteroids for 24 weeks
Number of subjects: 358
Study 18042591 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine for maintenance therapy with corticosteroids
Number of subjects: 358
Study 15088305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetylated fatty acid (CFA) topical cream
Number of subjects: 40
Study 15088305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11318042 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic group
Number of subjects: 204
Study 11318042 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 204
Study 11318042 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive subjects
Number of subjects: 204
Study 11318042 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 204
Study 9386902 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month special diet (17 subjects from the experimental group)
Number of subjects: 39
Study 9386902 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (hypercholesterolaemia)
Number of subjects: 39
Study 9386902 — intervention group
Group type: COMPARATOR
Intervention: Control group (39 healthy normocholesterolaemic subjects; 18 women and 21 men; mean age 43.7 ± 2.18 years)
Number of subjects: 39
Study 7943076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal prostaglandin E2 (2.5 mg)
Number of subjects: 100
Study 7943076 — intervention group
Group type: COMPARATOR
Intervention: Intracervical prostaglandin E2 (0.5 mg)
Number of subjects: 100
Study 3293887 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 25
Study 3293887 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzydamine mouthwash
Number of subjects: 25
Study 3293887 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 25
Study 29939502 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hypoglycemia
Number of subjects: 2273481
Study 29939502 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with insulin and sulfonylurea
Number of subjects: 2273481
Study 29939502 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of nephropathy
Number of subjects: 2273481
Study 28277398 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic showering for 30 minutes
Number of subjects: 32
Study 28277398 — intervention group
Group type: COMPARATOR
Intervention: Usual labor care
Number of subjects: 32
Study 24564262 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan-based antihypertensive treatment
Number of subjects: 873
Study 24564262 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol-based antihypertensive treatment
Number of subjects: 873
Study 24564262 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-ISH patients)
Number of subjects: 873
Study 22373002 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure at five true acupoints (NADA protocol)
Number of subjects: 60
Study 22373002 — intervention group
Group type: COMPARATOR
Intervention: Auricular acupressure at five sham points
Number of subjects: 60
Study 22373002 — intervention group
Group type: COMPARATOR
Intervention: No auricular acupressure at all
Number of subjects: 60
Study 20684786 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured practice nurse reviews with a specially prepared education booklet and comprehensive baseline assessment, followed by regular 3 monthly reviews over 2 years.
Number of subjects: 558
Study 20684786 — intervention group
Group type: COMPARATOR
Intervention: Usual care from general practice (control group).
Number of subjects: 558
Study 18331207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal electrocardiography (FECG) monitoring during labor
Number of subjects: 103
Study 18331207 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiotocography (CTG) monitoring during labor
Number of subjects: 103
Study 18331207 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical intervention based on significant CTG and ECG changes
Number of subjects: 103
Study 16884977 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-remifentanil
Number of subjects: 18
Study 16884977 — intervention group
Group type: COMPARATOR
Intervention: Propofol-remifentanil
Number of subjects: 18
Study 14979223 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple P-Positive Parenting Program (TP)
Number of subjects: 91
Study 14979223 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WL)
Number of subjects: 91
Study 10893895 — intervention group
Group type: EXPERIMENTAL
Intervention: Megadose heparin bolus (300 IU/kg body weight)
Number of subjects: 47
Study 10893895 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (1.5 million units over one hour)
Number of subjects: 47
Study 8671129 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy for Helicobacter pylori
Number of subjects: 164
Study 8671129 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-dyspeptic attenders)
Number of subjects: 164
Study 8355105 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg methylprednisolone orally the evening before surgery, combined with 20 mg methylprednisolone intravenously immediately preoperatively
Number of subjects: 11
Study 8355105 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 11
Study 8355105 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg methylprednisolone orally and 20 mg intravenously
Number of subjects: 11
Study 3125098 — intervention group
Group type: EXPERIMENTAL
Intervention: GRF 1-44 at 7.5 micrograms/kg
Number of subjects: 12
Study 3125098 — intervention group
Group type: EXPERIMENTAL
Intervention: GRF 1-44 at 15 micrograms/kg
Number of subjects: 12
Study 3125098 — intervention group
Group type: COMPARATOR
Intervention: Control (GH therapy)
Number of subjects: 12
Study 29966108 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE)
Number of subjects: 50
Study 29966108 — intervention group
Group type: COMPARATOR
Intervention: Standard facemask
Number of subjects: 50
Study 26195620 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced reciprocating gait orthosis with dorsiflexion-assist ankle-foot orthoses
Number of subjects: 10
Study 24096862 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous fitting of bilateral hearing aids
Number of subjects: 36
Study 24096862 — intervention group
Group type: COMPARATOR
Intervention: Sequential fitting of bilateral hearing aids
Number of subjects: 36
Study 23257685 — intervention group
Group type: EXPERIMENTAL
Intervention: mepolizumab (anti-IL-5 monoclonal antibody)
Number of subjects: 0
Study 23257685 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 20502294 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine wipes
Number of subjects: 5008
Study 20502294 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo wipes
Number of subjects: 5008
Study 18561877 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg bid
Number of subjects: 30
Study 18561877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30